Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.

Cancer
Bradley R CorrJennifer R Diamond

Abstract

Patients with ovarian cancer who are enrolled on phase 1 trials typically have platinum-resistant and heavily pretreated disease, with a poor prognosis. In the current study, the authors assessed prognostic factors and survival in women with recurrent ovarian cancer who were treated on phase 1 clinical trials. The authors performed a retrospective analysis of patients treated from 2008 through 2018 at the University of Colorado Cancer Center. Patient characteristics and treatment and toxicity-related survival data were assessed. Descriptive statistics and Cox proportional hazards models were used to identify risk factors associated with survival time. A total of 132 patients were treated on phase 1 clinical trials. Patients had a median age of 59 years (range, 33-88 years) with a median of 5.5 previous chemotherapy lines (range, 1-13 lines). Of the 132 patients, 53 (40%) were treated on multiple phase 1 trials with a median of 1 (range, 0-5) prior phase 1 trial. The overall response rate was 14.7%. The median overall survival was 11.3 months (95% CI, 9.1-13.4 months). Two patients died on trial due to progression of disease whereas no patients died of treatment-related toxicity. Independent risk factors found to be predictive o...Continue Reading

References

Jan 1, 1990·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G DecosterE E Holdener
Aug 27, 1982·JAMA : the Journal of the American Medical Association·M B Lipsett
Apr 13, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T BachelotM Clavel
Aug 28, 2003·JAMA : the Journal of the American Medical Association·Manish Agrawal, Ezekiel J Emanuel
Nov 4, 2004·JAMA : the Journal of the American Medical Association·Thomas G RobertsJeffrey W Clark
Mar 5, 2005·The New England Journal of Medicine·Elizabeth HorstmannChristine Grady
Mar 5, 2005·The New England Journal of Medicine·Razelle Kurzrock, Robert S Benjamin
Nov 29, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ItalianoJ-C Soria
Mar 29, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer WhelerRazelle Kurzrock
May 23, 2012·Cancer Prevention Research·Melinda M ProtaniPenelope M Webb
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Pujade-LauraineIsabelle Ray-Coquard
Apr 29, 2014·Lancet·Gordon C JaysonJonathan A Ledermann
Jul 8, 2015·British Journal of Cancer·C M NagleUNKNOWN Ovarian Cancer Association Consortium
Feb 17, 2017·British Journal of Cancer·Shana J KimJoanne Kotsopoulos
Aug 7, 2019·Gynecologic Oncology·Abigail S ZamoranoAdetunji T Toriola
Aug 8, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Deborah K ArmstrongAnita M Engh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.